Bedrosian, Isabelle
The University of Texas MD Anderson Cancer Center
3 papers on CoChatORCID 0000-0002-8775-8361
Most cited papers
- Verified
Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
Bedrosian, I., Somerfield, M. R., Achatz, M. I., Boughey, J. C., Curigliano, G., Friedman, S., Kohlmann, W. K., Kurian, A. W., Laronga, C., Lynce, F., et al. (2024) · Journal of Clinical Oncology
BRCA gene mutations in cancerBreast Lesions and Carcinomas
Cited by 216
- Verified
A phase 3 study to determine the breast cancer risk reducing effect of denosumab in women carrying a germline BRCA1 mutation (BRCA-P Study).
Bhulani, N., Wood, M., Tsai, J., Bedrosian, I., Hopkins, J. O., Brunet, J., Michaelson-Cohen, R., Schmutzler, R. K., Evans, G. D., Gnant, M., et al. (2022) · Journal of Clinical Oncology
BRCA gene mutations in cancerPARP inhibition in cancer therapy
Cited by 10
- Verified
Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline Q and A
Kurian, A. W., Bedrosian, I., Kohlmann, W. K., Somerfield, M. R., & Robson, M. E. (2024) · JCO Oncology Practice
BRCA gene mutations in cancerBreast Lesions and Carcinomas
Cited by 8
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free